Literature DB >> 5676401

Hepatic disposition of phenoldibromphthalein disulfonate and sulfobromophthalein.

C D Klaassen, G Plaa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5676401     DOI: 10.1152/ajplegacy.1968.215.4.971

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


× No keyword cloud information.
  6 in total

1.  Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein.

Authors:  R W Milne; L A Larsen; K L Jørgensen; J Bastlund; G R Stretch; A M Evans
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  [Studies on hepatic storage capacity and maximum transport of sulfobromophthalein in chronic kidney failure].

Authors:  H Wernze; H J Spech
Journal:  Klin Wochenschr       Date:  1971-12-15

3.  Pharmacokinetics of biliary excretion in man V. Dibromosulfophthalein.

Authors:  D K Meijer; J G Weitering; G A Vermeer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Heterogeneity of rat hepatocytes in bile acid and DBSP transport studied after induction of selective acinar damage by N-hydroxy-2-acetylaminofluorene and carbon tetrachloride.

Authors:  G M Groothuis; J G Weitering; K P Keulemans; M J Hardonk; D Mulder; D K Meijer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

5.  Formation of a metabolite of dibromosulfophthalein (DBSP) in man.

Authors:  D K Meijer; J G Weitering; B L Bajema; G A Vermeer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Dibromosulphophthalein: its pharmacokinetics and binding to hepatic cytosol proteins in rats with acute renal failure.

Authors:  D J Silberstein; C J Bowmer; M S Yates
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.